Product Details for NDA 011751
PROLIXIN (FLUPHENAZINE HYDROCHLORIDE)
2.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
2.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: FLUPHENAZINE HYDROCHLORIDE
Proprietary Name: PROLIXIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N011751
Product Number: 005
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
PROLIXIN (FLUPHENAZINE HYDROCHLORIDE)
Proprietary Name: PROLIXIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N011751
Product Number: 005
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: FLUPHENAZINE HYDROCHLORIDE
Proprietary Name: PROLIXIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N011751
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
PROLIXIN (FLUPHENAZINE HYDROCHLORIDE)
Proprietary Name: PROLIXIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N011751
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: FLUPHENAZINE HYDROCHLORIDE
Proprietary Name: PROLIXIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N011751
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
PROLIXIN (FLUPHENAZINE HYDROCHLORIDE)
Proprietary Name: PROLIXIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N011751
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: FLUPHENAZINE HYDROCHLORIDE
Proprietary Name: PROLIXIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N011751
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
PROLIXIN (FLUPHENAZINE HYDROCHLORIDE)
Proprietary Name: PROLIXIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N011751
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: FLUPHENAZINE HYDROCHLORIDE
Proprietary Name: PROLIXIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N011751
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: PROLIXIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N011751
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information